col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


97 Results       Page 1

 [1] 
Springer-Verlag: Annals of Hematology
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2024―Mar―25 The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study Haixia Fu, Xuan Cai, Lijuan Cui, Weixia Nong, Wenqian Li, Heng Mei, Tonghua Yang, Han Yue, Qiusha Huang, Zhuoyu An, Yejun Wu, Xiaojun Huang, Xiaohui Zhang, Tongfei Meng, Sujun Gao, Jianyong Li, Xiequn Chen, Mimi Shu, Shaoyuan Wang, Xiaobing Huang, Ming Jiang, Hailong Yuan, Yongrong Lai, Peng Cheng, Hu Zhou, Fei Li, Ruibin Huang, Zhongxing Jiang, Fang Wang, Liping Ma, Liping Su, Jishi Wang, Peng Zhao, Jianping Shen, Lihong Li, Peng Liu, Yunfeng Cheng, Qifa Liu, Jieyu Ye, Ting Niu, Hebing Zhou, Xi Zhang, Liangming Ma, Yajing Xu, Jie Peng, Hui Liu, Ru Feng, Zhao Wang, Yanqiu Han, Xin Li, Xin Du, Yi Liu, Feng Gao, Zhen Cai, Zhenling Li, Yuying Li, Peng Hu, Ruinan Lu, Yan Wang, Meijuan Huang, Jiawen Huang, Yun Li, Wenhua Zhou, Shixuan Wang, Ran Wang, Guoyang Zhang, Jing Ning, Li Ma, Liqiang Wu, Fan Yu, Xiang Liu, Yuanyuan Zhang, Yong Zhang, Xiaorui Wang, Yimei Feng, Yanyan Niu, Gaochao Zhang, Jing Zhang, Ruiheng Luo, Chengwei Luo, Li Li, Shuqing Feng, Jing Chen, Yang Li
2 [GO] 2024―Mar―04 Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies Patrick Reimann, Verena Petzer, Axel Mündlein, Bernd Hartmann, Luciano Severgnini, Alex Winkler, Theresia Lang, Minh Huynh, Klaus Gasser, Julia Rüger, Michele Atzl, Sylvia Mink, Peter Fraunberger, Stefan Schmidt, Normann Steiner, Andrea Griesmacher, Eberhard Gunsilius, David Nachbaur, Wolfgang Willenbacher, Dominik Wolf, Thomas Winder, Magdalena Anna Benda
3 [GO] 2024―Feb―21 Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort study Shuang Fan, Xiaodong Mo, Xiaohui Zhang, LanPing Xu, Yu Wang, Chenhua Yan, Huan Chen, Yuanyuan Zhang, Yifei Cheng, Yuqian Sun, Yuhong Chen, Yao Chen, Wei Han, Jingzhi Wang, Fengrong Wang, Zhengli Xu, Xiaojun Huang
4 [GO] 2024―Feb―13 Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers Rasoul Ebrahimi, Fatemeh Nasri, Tahereh Kalantari
5 [GO] 2024―Jan―03 Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia Simona Leoni, Rayan Bou-Fakhredin, Francesca Granata, Elena Cassinerio, Marco Maggioni, Anna Ludovica Fracanzani, Maria Domenica Cappellini, Irene Motta
6 [GO] 2023―Dec―28 Clinical characteristics of SARS-CoV-2 Omicron variant infection in children with acute leukemia Pengli Huang, Henghui Chang, Ruidong Zhang, Ying Wu, Peijing Qi, Yaguang Peng, Xueling Zheng, Huyong Zheng
7 [GO] 2023―Dec―14 Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study Ivo Demel, David Skopal, Eliška Šafránková, Petra Rozsívalová, Pavel Jindra, Jiří Šrámek, Adéla Turková, Jan Vydra, Klára Labská, Jana Vedrová, Martin Čerňan, Tomáš Szotkowski, Heidi Móciková, Lenka Hynková, Ondrej Šušol, Ingrid Kováčová, David Belada, Roman Hájek
8 [GO] 2023―Nov―30 COVID-19 vaccine-induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis Akbar Dorgalaleh, Ashkan Shabannezhad, Saeed Hassani
9 [GO] 2023―Nov―27 Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab Yuemin Gong, Xinyu Zhang, Xiaoyu Chen, Hui Yang, Yawen Zhang, Guangsheng He, Jianyong Li
10 [GO] 2023―Nov―11 Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study Odil Giladi, Gianmarco Bagnato, Marianna Gentilini, Shai Shimony, Oren Pasvolsky, Tamar Berger, Gilad Itchaki, Pia Raanani, Ginerva Lolli, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Pier Luigi Zinzani, Ronit Gurion
11 [GO] 2023―Oct―02 Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more anti-SARS-CoV-2 vaccine doses: a single center analysis of 64 cases Nicola Sgherza, Paola Curci, Rita Rizzi, Olga Battisti, Alberto Perfetto, Stefania Weigl, Angela M. V. Larocca, Maria Chironna, Silvio Tafuri, Pellegrino Musto
12 [GO] 2023―Aug―15 Association between ABO blood group/genotype and COVID-19 in a Japanese population Tatsuya Kusumoto, Shotaro Chubachi, Ho Namkoong, Hiromu Tanaka, Ho Lee, Shuhei Azekawa, Shiro Otake, Kensuke Nakagawara, Takahiro Fukushima, Atsuho Morita, Mayuko Watase, Kaori Sakurai, Takanori Asakura, Katsunori Masaki, Hirofumi Kamata, Makoto Ishii, Naoki Hasegawa, Norihiro Harada, Tetsuya Ueda, Soichiro Ueda, Takashi Ishiguro, Ken Arimura, Fukuki Saito, Takashi Yoshiyama, Yasushi Nakano, Yoshikazu Mutoh, Yusuke Suzuki, Ryuya Edahiro, Hirohito Sano, Yasunori Sato, Yukinori Okada, Ryuji Koike, Yuko Kitagawa, Katsushi Tokunaga, Akinori Kimura, Seiya Imoto, Satoru Miyano, Seishi Ogawa, Takanori Kanai, Koichi Fukunaga
13 [GO] 2023―Aug―14 Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era Feiyang Qi, Mei Bao, Hanlin Gao, Xiaoshuai Zhang, Shasha Zhao, Chenglei Wang, Wenwen Li, Qian Jiang
14 [GO] 2023―Jul―13 Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region Alessia Sticchi Damiani, Antonella Zizza, Federico Banchelli, Maddalena Gigante, Maria Lucia De Feo, Angelo Ostuni, Valerio Marinelli, Serena Quagnano, Pierpaolo Negro, Nicola Di Renzo, Marcello Guido
15 [GO] 2023―Jul―12 Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease Qing He, Xuelin Dou, Yang Liu, Lei Wen, Fengrong Wang, Nan Peng, Lizhong Gong, Yue Li, Yao Lu, Liru Wang, Xiaohui Zhang, Xiaojun Huang, Jin Lu
16 [GO] 2023―Jul―05 COVID-19 and β-thalassemia: in lieu of evidence and vague nexus Hayder M. Al-Kuraishy, Mohamed H. Mazhar Ashour, Hebatallah M. Saad, Gaber El-Saber Batiha
17 [GO] 2023―Jun―09 COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma Victoria R. Nachar, Anthony J. Perissinotti, Bernard L. Marini, Yasmin H. Karimi, Tycel J. Phillips
18 [GO] 2023―Apr―19 Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement Mohammad Sayyadi, Saeed Hassani, Mahmood Shams, Akbar Dorgalaleh
19 [GO] 2023―Apr―12 Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma Takashi Ishio, Shihori Tsukamoto, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Haruna Muraki, Mirei Kobayashi, Akio Mori, Masanobu Morioka, Takeshi Kondo
20 [GO] 2023―Apr―11 Gut microbiome alterations in patients with COVID-19-related coagulopathy Youli Chen, Xin Li, Cheng Yu, Erchuan Wang, Chang Luo, Yu Jin, Lei Zhang, Yanling Ma, Yan Jin, Ling Yang, Binlian Sun, Jialu Qiao, Xiang Zhou, Leo Rasche, Hermann Einsele, Jun Song, Tao Bai, Xiaohua Hou
21 [GO] 2023―Mar―26 G6PD deficiency-does it alter the course of COVID-19 infections? Tsz Yuen Au, Oskar Wojciech Wiśniewski, Shamiram Benjamin, Tadeusz Kubicki, Dominik Dytfeld, Lidia Gil
22 [GO] 2023―Mar―25 Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic Luca Guarnera, Elisa Buzzatti, Fabrizio Bonanni, Giovangiacinto Paterno, Antonella Riccitelli, Vittorio Forte, Adriano Venditti, Maria Ilaria Del Principe
23 [GO] 2023―Mar―02 Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms Mirei Kobayashi, Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, Hajime Senjo, Takashi Ishio, Emi Yokoyama, Minoru Kanaya, Koh Izumiyama, Makoto Saito, Haruna Muraki, Masanobu Morioka, Takanori Teshima, Takeshi Kondo
24 [GO] 2023―Feb―27 COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group Martin Šimkovič, Peter Turcsányi, Martin Špaček, Jana Mihályová, Pavlína Ryznerová, Mária Maco, Pavel Vodárek, Dominika Écsiová, Hynek Poul, Heidi Móciková, Jana Zuchnická, Anna Panovská, Mohammad Lekaa, Martina Oršulová, Adéla Prchlíková, Lukáš Stejskal, Stanislava Mašlejová, Yvona Brychtová, Lucie Bezděková, Tomáš Papajík, Daniel Lysák, Marek Trněný, Lukáš Smolej, Michael Doubek
25 [GO] 2023―Feb―16 Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination Jeremy W. Jacobs, Garrett S. Booth, Brian D. Adkins
26 [GO] 2022―Dec―10 BRAF inhibitor treatment of classical hairy cell leukemia allows successful vaccination against SARS-CoV-2 Judith Konrat, Wiebke Rösler, Michael Roiss, Fabienne Meier-Abt, Corinne C. Widmer, Stefan Balabanov, Markus G. Manz, Thorsten Zenz
27 [GO] 2022―Nov―24 Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain Ariana Ortuzar, María Laura Fox, Juan Antonio Vera, Álvaro Lorenzo Vizcaya, Alberto Marín Sánchez, Inmaculada Llopis Calatayud, Sara Carbonell, Alberto Álvarez-Larrán, Raquel Mata Serna, Josefa E. Marco Buades, Keina Quiroz Cervantes, Ángela Martínez Hellín, Alejandra Blum Domínguez, Gonzalo Caballero Navarro, Amparo Cáceres Sansaloni, Lucía Guerrero Fernández, Cristina Muñoz Linares, Mercedes Gasior Kabat, Raúl Pérez López, Ángeles Fernández Rodríguez, Cristina Martínez Bilbao, María Teresa Cobo Rodríguez, Álvaro Díaz, M. Antonia Durán, Marta Santaliestra Tomas, Valentín García-Gutierrez, Elena Magro Mazo, Juan Carlos Hernández-Boluda, Adrián Segura, José María Raya, Begoña Navas Elorza, Santiago Osorio
28 [GO] 2022―Nov―18 CD19 CAR T-cell infusion during severe COVID-19 acute respiratory distress syndrome in large B-cell lymphoma Nina Buchtele, Philipp Wohlfarth, Thomas Staudinger, Peter Schellongowski, Ludwig Traby, Matthias Vossen, Hanna Knaus, Elisabeth Lobmeyr, Werner Rabitsch, Nina Worel, Philipp B. Staber
29 [GO] 2022―Nov―12 New-onset Evans syndrome in a patient with SLE post SARS-CoV2 mRNA vaccination Timothy Y. M. Ng, Winnie Z. Y. Teo, Terence Y. M. Ng, Gim Gee Teng
30 [GO] 2022―Oct―22 Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection Panagiotis T. Diamantopoulos, Christina-Nefeli Kontandreopoulou, Christos Stafylidis, Dimitra Vlachopoulou, Nefeli Giannakopoulou, Maria Vardaka, Anthi Mpouhla, Eleni Variami, Athanasios Galanopoulos, Vassiliki Pappa, Mina Psichogiou, Angelos Hatzakis, Nora-Athina Viniou
31 [GO] 2022―Aug―26 Amyloidosis and COVID-19: experience from an amyloid program in Canada Ellen Lewis, Nowell Fine, Robert J. H. Miller, Christopher Hahn, Sameer Chhibber, Etienne Mahe, Jason Tay, Peter Duggan, Sylvia McCulloch, Nizar Bahlis, Paola Neri, Victor H. Jimenez-Zepeda
32 [GO] 2022―Aug―02 B-cell-guided strategy for SARS-CoV2 vaccination after autologous stem cell transplantation for B-cell lymphoma - a case report Ben-Niklas Baermann, Paul Jäger, Guido Kobbe
33 [GO] 2022―Jul―14 An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19 Hideaki Matsuura, Sumie Fujii, Yusuke Matsui, Yukari Sugiura, Hidehiko Akiyama, Yasuo Miura
34 [GO] 2022―Jul―14 Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies Ferenc Magyari, László Imre Pinczés, Edit Páyer, Katalin Farkas, Szilvia Ujfalusi, Ágnes Diószegi, Máté Sik, Zsófia Simon, Gergely Nagy, Zsuzsanna Hevessy, Béla Nagy, Árpád Illés
35 [GO] 2022―Jul―08 Hemolytic anemia in COVID-19 Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ajeet Kaushik, Małgorzata Kujawska, Gaber El-Saber Batiha
36 [GO] 2022―Jul―02 Venous thromboembolism after COVID-19 mRNA vaccination Philip Murphy
37 [GO] 2022―Jul―02 Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients José Luis Piñana, Pablo Rodríguez-Belenguer, Dolores Caballero, Rodrigo Martino, Lucia Lopez-Corral, María-José Terol, Lourdes Vazquez, Marisa Calabuig, Gabriela Sanz-Linares, Francisca Marin-Jimenez, Carmen Alonso, Juan Montoro, Elena Ferrer, Ana Facal, María-Jesús Pascual, Alicia Rodriguez-Fernandez, María T. Olave, Almudena Cascales-Hernandez, Beatriz Gago, José-Ángel Hernández-Rivas, Lucia Villalon, Magdalena Corona, Alicia Roldán-Pérez, Julia Ribes-Amoros, Clara González-Santillana, Ramon Garcia-Sanz, David Navarro, Antonio J. Serrano-López, Ángel Cedillo, Emilio Soria-Olivas, Anna Sureda, Carlos Solano
38 [GO] 2022―Jun―20 Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) Daniele Zama, Francesco Baccelli, Antonella Colombini, Amalia Contino, Elisabetta Calore, Maria Grazia Petris, Linda Meneghello, Federico Mercolini, Andrea Lo Vecchio, Shana Montalto, Cristina Meazza, Angelica Barone, Francesca Compagno, Paola Muggeo, Elena Soncini, Letizia Brescia, Eugenia Giraldi, Nagua Giurici, Rosa Maria Mura, Monica Cellini, Katia Perruccio, Valeria Petroni, Milena La Spina, Ottavio Ziino, Roberta Burnelli, Raffaella De Santis, Maurizio Mascarin, Valentina Barretta, Gloria Tridello, Simone Cesaro
39 [GO] 2022―May―24 SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness Malte B. Monin, Benjamin Marx, Lisa Meffert, Christoph Boesecke, Jürgen K. Rockstroh, Christian P. Strassburg, Peter Brossart, Annkristin Heine
40 [GO] 2022―May―21 Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases Jil Rotterdam, Margot Thiaucourt, Christel Weiss, Juliana Schwaab, Andreas Reiter, Sebastian Kreil, Laurenz Steiner, Sebastian Fenchel, Henning D. Popp, Wolf-Karsten Hofmann, Karin Bonatz, Catharina Gerhards, Michael Neumaier, Stefan A. Klein, Sonika Rao, Mohamad Jawhar, Susanne Saussele
41 [GO] 2022―Apr―11 COVID-19: impact of vaccination in myeloma patients E. Hoornaert, F. Dachy, A. Hansenne, S. Bailly, A. van Maanen, D. Gruson, M-C. Vekemans
42 [GO] 2022―Apr―07 Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies Ryutaro Taenaka, Teppei Obara, Kentaro Kohno, Kenichi Aoki, Ryosuke Ogawa
43 [GO] 2022―Mar―11 Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis Marko Lucijanic, Martina Demaria, Jelena Gnjidic, Zrinka Rob, Dora Filipovic, Toni Penovic, Ana Jordan, Mislav Barisic-Jaman, Frane Pastrović, Dijana Lucijanic, Tomislav Cikara, Tomo Lucijanic, Marko Miletic, Divo Ljubicic, Tatjana Keres
44 [GO] 2022―Feb―04 No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey Eriko Hamada, Kazuya Sakai, Shinya Yamada, Masayuki Kubo, Masaki Hayakawa, Masanori Matsumoto
45 [GO] 2022―Jan―27 Deep venous thrombosis and pulmonary embolism after COVID-19 mRNA vaccination Ali Atoui, Kawthar Jarrah, Layal Al Mahmasani, Rayan Bou-Fakhredin, Ali T. Taher
46 [GO] 2021―Dec―04 Hemophagocytosis, hyper-inflammatory responses, and multiple organ damages in COVID-19-associated hyperferritinemia Guiying Dong, Jianbo Yu, Weibo Gao, Wei Guo, Jihong Zhu, Tianbing Wang
47 [GO] 2021―Oct―18 ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis Yen-Ching Wang, Tsung-Chih Chen, Chieh-Lin Jerry Teng, Cheng-Han Wu
48 [GO] 2021―Oct―13 Autologous hematopoietic stem cell transplantation with concomitant SARS-CoV-2 infection Hanna A. Knaus, W. Rabitsch, N. Buchtele, J. Cserna, P. Wohlfarth
49 [GO] 2021―Oct―01 Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination Kei Saito, Satoshi Ichikawa, Shunsuke Hatta, Yuna Katsuoka, Hideo Harigae, Tohru Izumi
50 [GO] 2021―Sep―24 Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India Anshul Gupta, Nihar Desai, Priyanka Chauhan, Soniya Nityanand, Zia Hashim, Mansi Gupta
51 [GO] 2021―Sep―22 Impact of rituximab on COVID-19 outcomes Hannah Levavi, Guido Lancman, Janice Gabrilove
52 [GO] 2021―Sep―17 Mortality by COVID-19 in adults with acute myeloid leukemia: a survey with hematologists in Brazil Evandro M. Fagundes, Naira N. Neto, Lorena M. Caldas, Jordana R. Aragão, Ana Beatriz F. Gloria, Leonardo G. Leite, Paula Bastos, Carolina M. Fernandes, Mariana Chalup, Rosa Arcuri, Olivia G. Fagundes
53 [GO] 2021―Sep―13 Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue Robin Arcani, Julien Colle, Raphaël Cauchois, Marie Koubi, Pierre-André Jarrot, Rodolphe Jean, Arthur Boyer, Julie Lachamp, Antoine Tichadou, Anne-Laure Couderc, Laure Farnault, Regis Costello, Geoffroy Venton, Gilles Kaplanski
54 [GO] 2021―Aug―22 Association of blood type A with increased risk of severe COVID-19 in healthcare workers Niraj N. Mahajan, Rahul K. Gajbhiye, Periyasamy Kuppusamy, Shubhada Bahirat, Pradip D. Lokhande
55 [GO] 2021―Jul―26 Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience Marta Krejci, Ludek Pour, Zdenek Adam, Viera Sandecka, Martin Stork, Sabina Sevcikova, Martin Krejci, Zdenka Knechtova, Zdenek Kral
56 [GO] 2021―Jul―26 Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine Johannes Ruhe, Ulf Schnetzke, Karim Kentouche, Florian Prims, Michael Baier, Konstantin Herfurth, Mandy Schlosser, Martin Busch, Andreas Hochhaus, Gunter Wolf
57 [GO] 2021―Jul―24 Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis Giovanni Caocci, Olga Mulas, Daniela Mantovani, Alessandro Costa, Andrea Galizia, Luca Barabino, Marianna Greco, Roberta Murru, Giorgio La Nasa
58 [GO] 2021―May―25 Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals Can Boğa, Süheyl Asma, Göksel Leblebisatan, Nazan Şen, Anıl Tombak, Yusuf Ziya Demiroğlu, Mahmut Yeral, Şule Akın, Hasan Yeşilağaç, Mehmet Ali Habeşoğlu, Anış Arıboğan, Mutlu Kasar, Aslı Korur, Hakan Özdoğu
59 [GO] 2021―Mar―08 Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan
60 [GO] 2021―Feb―19 Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids Tien-Chan Hsieh, Oleg Sostin
61 [GO] 2021―Feb―02 Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy Irene Motta, Alessia Marcon, Maria Domenica Carrabba, Elena Cassinerio, Margherita Migone De Amicis, Adriana Branchi, Marianna Giuditta, Diletta Maira, Giovanna Fabio, Giovanna Graziadei, Marina Baldini
62 [GO] 2021―Feb―01 Hematologic changes predict clinical outcome in recovered patients with COVID-19 Jian Mao, Rong Dai, Rui-Chan Du, Yan Zhu, Li-Ping Shui, Xiao-Hua Luo
63 [GO] 2021―Feb―01 COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications Layal Al Mahmasani, Mohammad Hassan Hodroj, Antoine Finianos, Ali Taher
64 [GO] 2021―Jan―18 HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19 Luca Roncati, Antonio Manenti, Luca Fabbiani, Claudia Malagoli, Vincenzo Nasillo, Beatrice Lusenti, Massimo Lupi, Giuliana Zanelli, Tiziana Salviato, Matteo Costantini, Tommaso Trenti, Antonio Maiorana
65 [GO] 2021―Jan―07 Hematologic disorders associated with COVID-19: a review Mandeep Singh Rahi, Vishal Jindal, Sandra-Patrucco Reyes, Kulothungan Gunasekaran, Ruby Gupta, Ishmael Jaiyesimi
66 [GO] 2020―Nov―17 Questioning the association between ABO type and outcomes in patients with COVID-19 Jori E. May, Gerald McGwin, Radhika Gangaraju, Rita Paschal, Kaci Weaver, Jose L. O. Lima, Marisa B. Marques
67 [GO] 2020―Nov―13 Blood and platelet transfusion from a donor with presymptomatic Covid-19 Konstantinos Liapis, Menelaos Papoutselis, Georgios Vrachiolias, Christina Misidou, Emmanouil Spanoudakis, Zoe Bezirgiannidou, Aikaterini Pentidou, Theocharis Konstantinidis, Ioannis Kotsianidis
68 [GO] 2020―Nov―10 Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report Hannah Schüller, Franziska Klein, Michael Lübbert, Eric Peter Prager
69 [GO] 2020―Nov―07 COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry Maria Madeleine Rüthrich, C. Giessen-Jung, S. Borgmann, A. Y. Classen, S. Dolff, B. Grüner, F. Hanses, N. Isberner, P. Köhler, J. Lanznaster, U. Merle, S. Nadalin, C. Piepel, J. Schneider, M. Schons, R. Strauss, L. Tometten, J. J. Vehreschild, M. von Lilienfeld-Toal, G. Beutel, K. Wille
70 [GO] 2020―Nov―06 Plasma hemoglobin in COVID-19: authors’ reply Guido Lancman, Bridget K. Marcellino, Santiago Thibaud, Kevin Troy
71 [GO] 2020―Oct―20 Characteristics of coagulation alteration in patients with COVID-19 Hong-chun Luo, Cheng-yan You, Si-wei Lu, Yue-qiang Fu
72 [GO] 2020―Oct―07 Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Caterina Musolino
73 [GO] 2020―Sep―24 Elevated plasma hemoglobin in COVID-19-related illnesses: a critical appraisal Nishant R. Tiwari, Nagnath K. Redewad, Apurva A. Ketkar, Vivek R. Sharma
74 [GO] 2020―Sep―12 Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection Abdulrahman A. Algassim, Assem A. Elghazaly, Abdulrahman S. Alnahdi, Owais M. Mohammed-Rahim, Abdulaziz G. Alanazi, Nawaf A. Aldhuwayhi, Mashael M. Alanazi, Mohammed F. Almutairi, Ibrahim M. Aldeailej, Najeeb A. Kamli, Mahmoud D. Aljurf
75 [GO] 2020―Aug―28 High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19 Luca Roncati, Giuliano Bergonzini, Beatrice Lusenti, Vincenzo Nasillo, Ambra Paolini, Giuliana Zanelli, Stefania Corrado
76 [GO] 2020―Aug―17 Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience Ahmad Hanif, Sumera Khan, Nikhitha Mantri, Sana Hanif, Muhamed Saleh, Yamini Alla, Siddharth Chinta, Nikee Shrestha, Wenyan Ji, Kristopher Attwood, Muhammad Adrish, Kevin R. Jain
77 [GO] 2020―Aug―01 Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19 Guido Lancman, Bridget K. Marcellino, Santiago Thibaud, Kevin Troy
78 [GO] 2020―Jul―18 COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan Xiang Zhou, Tao Bai, Katharina Meckel, Jun Song, Yu Jin, K. Martin Kortüm, Hermann Einsele, Xiaohua Hou, Leo Rasche
79 [GO] 2020―Jul―18 Thrombocytopenia in COVID-19: pathophysiology matters Eleni Gavriilaki, Ioanna Sakellari, Maria Gavriilaki, Achilles Anagnostopoulos
80 [GO] 2020―Jul―12 Blood type and outcomes in patients with COVID-19 Christopher A. Latz, Charles DeCarlo, Laura Boitano, C. Y. Maximilian Png, Rushad Patell, Mark F. Conrad, Matthew Eagleton, Anahita Dua
81 [GO] 2020―Jun―29 Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments Yingying Wang, Jingfeng Li, Li Liu, Jianfang Li, Xiaoyan Liu, Jing He, Cong Wang, Dan Ye, Xinghuan Wang, Fuling Zhou
82 [GO] 2020―Jun―26 SARS-CoV-2-associated cold agglutinin disease: a report of two cases Tessa Huscenot, Joris Galland, Margot Ouvrat, Mathias Rossignol, Stéphane Mouly, Damien Sène
83 [GO] 2020―Jun―25 IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection Carolina Villegas, María Poza, Paloma Talayero, José Manuel Caro Teller, Denis Zafra, Cristina Garcia, Elena Vera, Marta Hidalgo, Nieves Lopez, Clara Cuellar, Irene Zamanillo, Rodrigo Íñiguez, Estela Paz-Artal, José M. Aguado, J. Martinez-Lopez
84 [GO] 2020―Jun―24 COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure Monia Marchetti
85 [GO] 2020―Jun―23 COVID-19, impact on myeloma patients Inès Dufour, Juliette Raedemaeker, Fabio Andreozzi, Géraldine Verstraete, Sarah Bailly, Michel Delforge, Pauline Storms, Caroline Jacquy, Ann Van de Velde, Philippe Mineur, Marie Lejeune, Deborah Bauwens, Florence Van Obbergh, Alain Kentos, Jasmine Nguyen, Karel Fostier, Anne De Weweire, Nathalie Meuleman, Marie-Christiane Vekemans
86 [GO] 2020―Jun―16 COVID-19 infection associated with autoimmune hemolytic anemia Antoine Capes, Sarah Bailly, Philippe Hantson, Ludovic Gerard, Pierre-François Laterre
87 [GO] 2020―Jun―13 COVID-19 presenting as neutropenic fever Hunter C. Spencer, Riana Wurzburger
88 [GO] 2020―Jun―13 SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone Giuseppe Visani, Martina Chiarucci, Barbara Guiducci, Maria Capalbo, Alessandro Isidori
89 [GO] 2020―Jun―12 SARS-CoV-2 infection in children with febrile neutropenia Victoria Flores, Raquel Miranda, Laura Merino, Carmen González, Cristina Serrano, Moises Solano, Jessica Herrera, Paulina González, Genesis Ruiz, Ricardo Saldaña, Ahtziri Cárdenas, Lénica A. Chávez-Aguilar
90 [GO] 2020―Jun―11 Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection Michele Merli, Walter Ageno, Fausto Sessa, Marco Salvini, Domenica Caramazza, Barbara Mora, Agostino Rossi, Cristina Rovelli, Francesco Passamonti, Paolo Grossi
91 [GO] 2020―Jun―04 Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report Zhiliang Hu, Wei Chen, Wenyan Liang, Chuanjun Xu, Wenkui Sun, Yongxiang Yi
92 [GO] 2020―Jun―03 Hematological findings in coronavirus disease 2019: indications of progression of disease Xiaoqing Liu, Run Zhang, Guangsheng He
93 [GO] 2020―May―27 Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19 Nil Albiol, Rahinatu Awol, Rodrigo Martino
94 [GO] 2020―May―24 Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease Luca Roncati, Beatrice Lusenti, Vincenzo Nasillo, Antonio Manenti
95 [GO] 2020―May―14 Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)? Giovanni Caocci, Giorgio La Nasa
96 [GO] 2020―May―08 Signals of Th2 immune response from COVID-19 patients requiring intensive care Luca Roncati, Vincenzo Nasillo, Beatrice Lusenti, Giovanni Riva
97 [GO] 2020―Apr―15 Mechanism of thrombocytopenia in COVID-19 patients Panyang Xu, Qi Zhou, Jiancheng Xu
 [1] 

97 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.014 sec